Following are six reasons why pharmaceutical and life sciences companies must prioritize track-and-trace technology in their logistics operations in 2025.

The long-promised tariffs scheduled to take effect March 4 would easily be among the most sweeping of the Trump era, applying to roughly $1.5 trillion in annual imports.

Adding FTZ or bonded warehousing capabilities can have a huge impact for 3PL providers, particularly in areas with high volumes of international trade.

U.S.-based companies are also likely to suffer because of reciprocal tariffs imposed by America’s trading partners in retaliation, threatening profit from exports. 

Prices will rise, maybe wages will too. The question is whether Trump’s new tariff regime will pay off. 

Shippers with complex needs and tight budgets are outsourcing more of their freight to managed transportation providers.

The bloc could move quickly by re-applying duties it first imposed on the U.S. during Trump’s first term. 

Can the U.S. pharmaceutical supply chain come home — or, at least, get closer to it?

The future contains much uncertainty, but also a wealth of opportunities for innovative and far-thinking enterprises.